SCALOP-2: A multi-centre randomised study of induction chemotherapy followed by capecitabine (+/- nelfinavir) with high or standard dose radiotherapy for locally advanced non-metastatic pancreatic cancer

SCALOP-2: A multi-centre randomised study of induction chemotherapy followed by capecitabine (+/- nelfinavir) with high or standard dose radiotherapy for locally advanced non-metastatic pancreatic cancer

Chemotherapy followed by consolidation chemoradiotherapy (CRT) is a treatment option for locally advanced non-metastatic pancreatic cancer (LAPC), but outcome remains poor. The SCALOP trial identified a feasible, safe, and effective CRT regimen for LAPC: capecitabine (830mg/m2 oral bd) as radiosensi...

Full description

Bibliographic Details
Main Authors:	Virdee, P, Shaw, R, Strauss, V, Hamill, C, Hurt, C, Corrie, P, Bridgewater, J, Parsons, P, Tranter, B, Sebag-Montefiore, D, Chu, K, Radhakrishna, G, Hawkins, M, O'Neill, E, Campbell, S, Love, S, Maughan, T, Mukherjee, S
Format:	Conference item
Published:	Oxford University Press 2017

Similar Items

P-233: SCALOP-2: A multi-centre randomised study of induction chemotherapy followed by capecitabine (+/- nelfinavir) with high or standard dose radiotherapy for locally advanced non-metastatic pancreatic cancer
by: Virdee, P, et al.
Published: (2017)

Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2)
by: Strauss, V, et al.
Published: (2019)

Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2)
by: Victoria Y. Strauss, et al.
Published: (2019-02-01)

SCALOP-2: A multi-centre randomised trial of induction chemotherapy followed by capecitabine +/-nelfinavir with high or standard dose radiotherapy for locally advanced pancreatic cancer (LAPC): Results of stage 1 - the non-randomised dose-finding component
by: Mukherjee, S, et al.
Published: (2018)

SCALOP-2: A randomised trial of induction GEMABX followed by chemoradiation (high/standard dose radiation) +/-nelfinavir for locally advanced pancreatic cancer: results of the dose-finding component
by: Mukherjee, S, et al.
Published: (2018)

Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: the phase 1/randomised phase 2 SCALOP-2 trial
by: Mukherjee, S, et al.
Published: (2024)

Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial.
by: Mukherjee, S, et al.
Published: (2013)

Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer
by: Hurt, C, et al.
Published: (2017)

NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.
by: Mukherjee, S, et al.
Published: (2015)

NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.
by: Mukherjee, S, et al.
Published: (2015)

NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
by: Mukherjee, S, et al.
Published: (2017)

Preliminary phase IISOCRATES study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (IRT) in patients (pts) with locally advanced rectal cancer (LARC).
by: Glynne-Jones, R, et al.
Published: (2004)

ARCII: Nelfinavir, a hypoxia-modifying agent, in combination with chemoradiotherapy (CRT) in locally-advanced pancreatic cancer (LAPC)–mechanism and clinical outcomes
by: Wilson, J, et al.
Published: (2017)

Dosimetric parameters predict toxicity in chemoradiotherapy with nelfinavir for pancreatic cancer
by: Holyoake, D, et al.
Published: (2016)

Socrates phase II study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (RT) in patients (pts) with locally advanced rectal cancer (LARC).
by: Glynne-Jones, R, et al.
Published: (2005)

Comparison of investigator-delineated gross tumour volumes and quality assurance in pancreatic cencer: Analysis of the on-trial cases for the SCALOP trial
by: Fokas, E, et al.
Published: (2015)

SCALOP: sequence-based antibody canonical loop structure annotation
by: Wong, W, et al.
Published: (2018)

Spectrophometric Determination of Nelfinavir Mesylate
by: K. Vanitha Prakash, et al.
Published: (2006-01-01)

Induction of Suicidal Erythrocyte Death by Nelfinavir
by: Rosi Bissinger, et al.
Published: (2015-05-01)

The cytotoxic activity of carfilzomib together with nelfinavir is superior to the bortezomib/nelfinavir combination in non-small cell lung carcinoma
by: Lenka Besse, et al.
Published: (2023-03-01)

Clinical trial of oral nelfinavir before and during radiation therapy for advanced rectal cancer
by: Hill, E, et al.
Published: (2016)

Nelfinavir: An Old Ally in the COVID-19 Fight?
by: Anna Gidari, et al.
Published: (2022-12-01)

Toxicity, tolerability & compliance of concurrent capecitabine or 5-fluorouracil in the radical management of anal cancer with single-dose mitomycin-C and intensity modulated radiation therapy: evaluation of a national cohort
by: Jones, C, et al.
Published: (2018)

A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS
by: Gollins, S, et al.
Published: (2019)

Conformity analysis of target-volume definition for margin-directed boost in pancreatic cancer SBRT
by: Holyoake, D, et al.
Published: (2016)

Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children
by: Léon Juan, et al.
Published: (2006-07-01)

Pharmacoeconomic analysis of Capecitabine in the adjuvant setting. Results from the X-ACT trial comparing capecitabine with 5-FU/LV in patients with Dukes' C colon cancer
by: Douillard, J, et al.
Published: (2004)

A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study.
by: Sebag-Montefiore, D, et al.
Published: (2005)

A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.
by: Glynne-Jones, R, et al.
Published: (2007)

Analysis of on-trial quality assurance for the SPARC clinical trial using novel peer-review methodology
by: Holyoake, D, et al.
Published: (2018)

ARCII: A Phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer
by: Wilson, J, et al.
Published: (2016)

The radiosensitizing effects of Nelfinavir on pancreatic cancer with and without pancreatic stellate cells
by: Al-Assar, O, et al.
Published: (2016)

The efficacy of nelfinavir and lopinavir/ritonavir in the treatment of HIV-infected pediatric patients
by: V. B. Denisenko,, et al.
Published: (2018-12-01)

RP-HPLC Method for the Estimation of Nelfinavir Mesylate in Tablet Dosage Form
by: K. Vanitha Prakash, et al.
Published: (2007-01-01)

Efeitos do uso crônico do nelfinavir sobre a prenhez da rata albina: ensaio biológico Effects of chronic nelfinavir treatment on rat pregnancy: biological assay
by: Camila Fernandes Venneri Mathias, et al.
Published: (2006-03-01)

Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial
by: Kerr, R, et al.
Published: (2016)

Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial
by: Love, S, et al.
Published: (2016)

Conformity analysis to demonstrate reproducibility of target volumes for Margin-Intense Stereotactic Radiotherapy for borderline-resectable pancreatic cancer.
by: Holyoake, D, et al.
Published: (2016)

Modulation of myocardial creatine transporter levels and the effects of gene regulation and post-translational modification on its function
by: Sebag-Montefiore, L
Published: (2012)

Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment
by: Ohashi, H, et al.
Published: (2021)